<SEC-DOCUMENT>0001193125-11-283809.txt : 20111027
<SEC-HEADER>0001193125-11-283809.hdr.sgml : 20111027
<ACCEPTANCE-DATETIME>20111027133353
ACCESSION NUMBER:		0001193125-11-283809
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20111021
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20111027
DATE AS OF CHANGE:		20111027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		111161236

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		9492601200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d248385d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of earliest event reported): October&nbsp;21, 2011 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>AMERICAN VANGUARD CORPORATION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>001-13795</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>95-2588080</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4695 MacArthur Court</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Newport Beach, California</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>92660</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: (949)&nbsp;260-1200 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;8.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Events </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On
October&nbsp;21, 2011 the Company issued a press release announcing that its wholly-owned subsidiary, AMVAC Chemical Corporation (&#147;AMVAC&#148;), had completed the acquisition of the international assets of the cotton defoliant product tribufos
from Bayer CropScience AG. A complete copy of that press release is attached hereto as Exhibit 99.1. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October 27, 2011 the
Company issued a press release announcing that its wholly-owned subsidiary, AMVAC, had licensed certain biopesticide rights from Summerdale Incorporated. A complete copy of that press release is attached hereto as Exhibit 99.2. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)
Exhibits </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit 99.1 Press release dated October&nbsp;21, 2011 of American Vanguard Corporation. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit 99.2 Press release dated October&nbsp;27, 2011 of American Vanguard Corporation. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">AMERICAN VANGUARD CORPORATION</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: October&nbsp;27, 2011</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Timothy J. Donnelly</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Timothy J. Donnelly</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Administrative Officer, General Counsel&nbsp;&amp;&nbsp;Secretary</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INDEX TO EXHIBITS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release dated October 21, 2011 of American Vanguard Corporation.</FONT></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">99.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release dated October 27, 2011 of American Vanguard Corporation.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d248385dex991.htm
<DESCRIPTION>PRESS RELEASE DATED OCTOBER 21, 2011
<TEXT>
<HTML><HEAD>
<TITLE>Press release dated October 21, 2011</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">


<IMG SRC="g248385frr.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>FOR IMMEDIATE RELEASE </U></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>AMERICAN VANGUARD EXPANDS COTTON DEFOLIANT BUSINESS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px;"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Newport Beach, CA &#150; October&nbsp;21, 2011 &#150; American Vanguard Corporation (NYSE:AVD) today announced that its wholly owned subsidiary Amvac Chemical Corporation has acquired the international
assets of the cotton defoliant product tribufos (sold under the trade name Def<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>) from Bayer CropScience. The
acquisition of this international segment completes Amvac&#146;s July 2010 purchase of Bayer&#146;s domestic tribufos product line and complements the Company&#146;s existing tribufos product Folex<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, which it has marketed since 2002. The acquired product is registered for use in Mexico, Argentina, Costa Rica and Colombia. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Folex is a fast and effective cotton defoliant that facilitates the removal of leaves surrounding the cotton boll and in combination with other products
functions as a harvest aid. It enables cotton growers to utilize highly productive mechanical harvesting methods and to optimize their yield regardless of variable weather conditions present at harvest time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alfredo Pelaez, Amvac&#146;s Director of International Sales commented: &#147;This acquisition strengthens Amvac&#146;s access to the international
cotton market particularly in the Central and South American regions. We will be increasing our direct selling efforts in Mexico, expanding our distribution in Argentina, and beginning to develop our participation in the substantial cotton growing
market of Brazil.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glen Johnson, Amvac&#146;s Senior VP and Director of Business&nbsp;&amp; Product Development added: &#147;The
addition of this product to our portfolio is another example of our continuing effort to broaden our product offering and expand our geographic footprint. We will also benefit from manufacturing this product in our Axis, Alabama plant, as we
systematically increase the utilization of that facility with the additional production of several recently acquired products. With such acquisitions we expect to capitalize on the expansion of cotton acreage in the United States and elsewhere in
the world, as global demand and rising commodity prices encourage a greater focus on cultivating this essential crop.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About American
Vanguard </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">American Vanguard Corporation is a diversified specialty and agricultural products company that develops and
markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;&amp; Russell 3000<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>
Indexes and the Standard&nbsp;&amp; Poors 600 Index. To learn more about American Vanguard, please reference the Company&#146;s web site at <U>www.american-vanguard.com.</U> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In its public commentary, the Company may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the
Company&#146;s management subject to various risks and uncertainties that may cause results to differ from management&#146;s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed in
the Company&#146;s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company&#146;s judgment as of the date of this release. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CONTACT: </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">American Vanguard Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Equity Group Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William A. Kuser, Director of Investor Relations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">www.theequitygroup.com</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(949) 260-1200</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lena Cati (212) 836-9611</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">williamk@amvac-chemical.com</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lcati@equityny.com</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d248385dex992.htm
<DESCRIPTION>PRESS RELEASE DATED OCTOBER 27, 2011
<TEXT>
<HTML><HEAD>
<TITLE>Press release dated October 27, 2011</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.2 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><U>


<IMG SRC="g24838500001.jpg" ALT="LOGO">
 </U></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><U>FOR IMMEDIATE RELEASE </U></B></FONT></P>
<P STYLE="margin-top:14px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>AMERICAN VANGUARD LICENSES BIOPESTICIDE RIGHTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Newport Beach, Ca &#150; October&nbsp;27, 2011&#151;American Vanguard Corporation (NYSE:AVD) today announced that its wholly owned subsidiary AMVAC Chemical Corporation has licensed the rights to two
recently issued U.S. patents from Summerdale Incorporated (Verona, Wisconsin, USA). This exclusive licensing agreement grants AMVAC worldwide rights to develop patented products for pre-harvest and post-harvest commercial crop protection uses as
fungicides, sanitizers, desiccants and/or harvest aids. One of the lead candidates, AMV4024, has been in development for more than three years, and shows good potential as a broad-spectrum bio-fungicide. In addition, another candidate, AMV5680 is
also being tested as a crop desiccant aid. Other lead compounds may be evaluated for further development as sanitizers or for other post-harvest uses. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px;"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Glen Johnson, AMVAC&#146;s Senior VP and Director of Business&nbsp;&amp; Product Development commented: &#147;Securing these valuable licensing rights allows us to develop a broad range of products in
different market segments and will continue to expand AMVAC&#146;s biopesticide product line into the future. AMVAC&#146;s green portfolio began with the acquisition of exclusive marketing rights in 1999 to develop and launch azadirachtin-based
products with unique formulation technology&#151; Ornazin<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and Ecozin<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> Plus and continued to build with the licensing of patented potato sprout inhibitor technology from Washington State
University in 2005. Since obtaining this exclusive license from WSU, AMVAC now has successfully developed and globally tested the active ingredient, 3-decen-2-one (SmartBlock<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> coded as AMV1018), and presently awaits both U.S. and Canadian registrations. We believe that SmartBlock which is also an FDA-approved direct food additive, will
enjoy considerable commercial success world-wide, based on excellent product performance and unique market needs. Pursuing such new green technology avenues together with our proven success in marketing conventional crop protection chemicals, will
further broaden our portfolio and help AMVAC meet an ever-increasing global demand for food, feed, fiber and biofuels.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About
American Vanguard </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">American Vanguard Corporation is a diversified specialty and agricultural products company that
develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;&amp; Russell 3000<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>
Indexes and the Standard&nbsp;&amp; Poors 600 Index. To learn more about American Vanguard, please reference the Company&#146;s web site at <U>www.american-vanguard.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In its public commentary, the Company may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the
Company&#146;s management subject to various risks and uncertainties that may cause results to differ from management&#146;s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed in
the Company&#146;s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company&#146;s judgment as of the date of this release. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CONTACT: </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">American Vanguard Corporation</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">William A. Kuser, Director of Investor Relations</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(949) 260-1200</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">williamk@amvac-chemical.com</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Equity Group Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">www.theequitygroup.com</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lena Cati
(212)&nbsp;836-9611</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lcati@equityny.com</FONT></P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g24838500001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g24838500001.jpg
M_]C_X``02D9)1@`!`0$`>`!X``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``\`0`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#TSQKXAU+1
M0#8R(I(_BC#8XKRFZ^+?B^&X9%O+4`'I]G4XKT#XF,0,=!M&?I7A%VDDEYL1
M2\CG"JH)+$G@`>]?5Y7A*%2@I3@GZGBUZ]15W%2.M;XR>-4)Q<63#/\`%;J/
MZU[SX2U*YU?PGIFHWFTW%Q;K)(57`R?05\SR>&1#X7;Q#>:A$L'VO[$L,$7F
M,9-NX\DA<`=P2*^CO`'_`"(.A?\`7E&?TKDSBEAHTDZ,4M;.R\CMPTIM^^^A
MT6]<XSS3J0@$8-1M$PYC<J?3M7SYVDM%51<O$=LR'_>'>IXY4E&48&FTT)23
MT'T444AA1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`>=?$9$8$RR>7&`,L1NR<=`._'T^O(KQN]L8[2PFNK>9I+BY5C&CKL=
M(!D/(`"<Y(*]<@!^,<CVCQ]9G4)4B\P1QJ"9GS_JT`!+D>@&?QP.XKQ2>==6
M\5"8/%;VBRI&JR3*@A@&%"_,1NPO7'7GUKZS*VW02OHM_P#+YGB5U^_;+_C)
M4T[P3X.T(DJSVTFHRJ.YE;*?B!N%>GV/B;4M"\,^`]*TK3K:[N=6M3$GVB<Q
M+&4B#!B0IXY)/&>..M>2_$VYM]4\8O+8W$$VFPPQ6MH\4JO\B*,C@DCYB>H%
M>X^&?#EIJOAWP1JL\DZ3Z39K)`L;`*Q>(*0V02>/0BN+-$UA*;>[;?WW?ZGH
M4/C:1BZ!\3]9U&YT)]0T*UM['4[R33C)#=%Y%G3/S;2H&PD8QG/!/IF)_C&B
M^)FM/(L!IZZI_994W1^V$[MOGB/;CRMW'7-=/9_#G2+*#2H8[F^9=-U"348=
MSIEI'R2&^7E>3P,'WI8?A_:6NM27UKK.LV]M+>F_DTZ&ZV6[S'DDX&[:3R5W
M8)[8XKP#K*VF^+M6UKQAJ^C1:)&-,TR=X;F^-P,_ZO<@5,=2>OH,5RVA^++Y
M/!O@^'2H)[[6=;,Z0+J-[N(6)F9WDEV@M@8X`''?CGT?2O#5GI%_K-Y;S7#2
M:M,)YP[*0C;=ORX`P,>N:Q%^&NF0:%HFFV>H:C:S:(\CV-]&Z>>F_.\'Y=I4
MYP1MZ`>^6FUL)Q3W,O4?B%K6C>&K:[U+1+:QU"6X\B1+Z]6**'&?GW`9<'&0
M%&>OIS''\5KBX\(:9J]KHT=S>7>LKI!MENMJ%SNPRN5Z'`QN`Z^U:L_PQTN3
M2]*M8=1U*&YTVX>YBOO,229Y'^^7WJ5.?IQ@5BS?#.'2;*VACO;^X@M-4&K1
MS,RF3S5YPYV\KG)SU]ZTC%3=EHS-R<%KJ=1X0\47NNW>LZ;JFGQ6>HZ3<+#,
ML$WFQN&7<K*2`>G8C_`0_$QM5MO`]YJ6C74T%[IS)>#RWVB1$.75O5=FXX[X
M%4_#YMM%UK6=2F,[RZM+'+,W!5"B;1M`&?U-=COL]4LY(LQSP2J8Y%Z@@C!!
M'T-*I2G3^)#A5C/9G`Q>*;R]\5:_K=E)-<:+H^D0^5:"98H[B>5?.WEF(480
MJ"3T!S3-,^*KW>G>(Y9K"QEGT:R6\!L+_P`^&4$$[/,VC#`C!QD=?2M6Q^%^
MBV'@&^\(1W%XUG>,7EG=QYI;Y<'(&.-BC&.@H3X<0.FKF]UO4;N?5K`6%Q(Z
MQ*%09`**J`+@'&.G?KS69H5]&^(EW=:R;/6M$&FPRZ2=6MY4NA,3"",AP%&&
MP<\9]*KZ/\2M4O\`4?#\=YX7-I9:^[_8KG[:'(C52V74+P2`"!GHW7BM]/!5
MC#JEIJ(DFGDM-).E+#*P$<D?!RV%SDXP<<>U>?\`AGP1KT7BSPU+-I^K66G:
M.T[,E_J4-S#"K*0B0;`&;.1RP&`,=N0#J1\2B=,M[S^R#F;Q#_8>S[1T^8KY
MN=O/3[OZU#KGQ/;1/%0TJ;2[8V_VR&SW'4HQ<L9,?O%MP"VP9ZDC/%3'X66O
M]HB8:YJ:V2:N-8BL1Y?EI/NW-SMW$'L,\<]2<TV\^%EO=7]_,FN7\%M>:BNI
MM:I'$1]H!!R6*[F7CA<@"@";_A8-T?$VMV']@R#2]#WM?ZE]I7$:"$R+B,@%
MB2",#IP<\UA6/C?Q'K7C?P-Y^F2:1I>JQW<RQBZ6874?D[HRP`!4CAL?[0YZ
M@=O9^$+"VO?$4\CR7":ZP-S#)@*`$V%1CG!!K%T;X:KI6L:'?S>(=3OET-98
MK"WG6,)'$Z;-I*J"2!CG/8#``H`[JO*=/7Q3XZE\0ZK8>*;G2GL=0FLM,M(8
MT\C]UCYI@5);<3SZ<]1Q7JU<%J7PQBNKK518^(-3TW3=8D,NHV%N4*2LPPY4
ML"4W?Q8Z].G%`%C4_%VLZ=>Z7H%GHT&K>(YK+[7=Q0W7D01(N%9@[@D@OD*,
M9]:H3_%)GT+0;_3=`N+VZU>>2T%D;A8WBG0$%2Q&,;AC)QA?FQVK6U3P%!-<
MZ;>:)J5SH=[I]I]AAEME60&WXQ&RN#D#&0>QYYXPVT^'>F6%OX<@MKFY5-#N
M)+A"Y#-.[@[BYQU)8GB@#/U/Q_KEGJ\^D67A(WM]:Z=%?W*B_6-8PP.Y,[3D
M@C`QG//3',DWQ'-Y!H,?AW1GU34-8MC=I;O<+`L$2_>+N0>=WR@`<D'GIFEK
M'@[7-7^(^K7MMJ-YI-C<Z5':_:[<1N)?F.]-K9(.#PPP1V-6G\':7-/IEGX=
MUB[TW4_#]M]E2ZMT24!&`RDNY=C,?O8Z@G..13LV!%<?%+;X<TK4K;0IY[V]
MU(Z7+I_GJKPW`W`KN(PW*CGC@YXZ4[Q5\2+[PK#:&YT.U29]/%Y<QW.JQ0['
M[PQ\$RN#GH,=/7B_!\.-.MM-T2SBO+HG2]2&IM-(0SW,V26+G'?=V]!3?$GP
M\C\0:Y=:FFL75B;S3SI]TD44;EXSNX5G4E,[N<=1Z=:0&?/XQUJZ\?\`A*VT
MV!?[&U;3VNW22159@5#9/RD@H".`<-GMBH-/\>MIOA[5KQX;W4+MO$<VE6-K
M+<(3+*6`1%;:H1.IYSCGDUO)X%CBOO#%Y!JEQ%/H-J+0$1J1<1;54A@1QD+U
M'K5=_AKI[Z'>Z<;ZZ62?5FUB"Z3:)+:X+`J4XP<=.>Q/3C`!4D^)5Q9:-XCD
MU/06M-6T*..6:R%TKI*DGW&64+]<_+Q5[PWXXO-8\42:%J6@2:7.]@NI6S&Y
M6;S("^SY@H&QLD<<]^>!F'_A6T5QH^OV^HZS=WNHZXD:7=^\:*0J<($10%4#
M]<ULV_A6&W\80^(A=2--'I0TL0E1M*B0/OSZY&*`.7^(UW+:QR"W9HV;&]P<
M$^@^F>W?\*\'U&=KB\>1]A8\'8@4?D,"OI?Q/X/;Q$25OOL^1C_5[OZBN`G^
M!5Q([,GB"($]C:'_`.+KZ?+,?A:-)*<K/T?^1Y%;#5I5G)+0\4FD1'![_A7U
MMX*&/`N@?]@Z#_T6M>2S?L_ZA(X8>(8..@^SL.?^^J]GT+3WTG0-.TUY%D:T
MM8X"ZC`8JH4D?E6&<XVAB(05*5[-G7AJ4H;HT****^?.P****`"BBB@#'U#0
M+>[R\6(I/8?*?J*Y:YBOM'N@5\Z%ST=?NMQZ]_QKT&HYH(KB,QS1K(AZJPR#
M751Q4H:2U1S5<-&>L=&<G8>,F3Y-1@)`_P"6L0_F/\*Z>SU&TU"/?:SI*!UV
MGD?4=17-ZIX.5]TNG.$.#^Y?I^!_QKC[FTN]-O,R++:SJ.&SM/U!'X=#76L-
MA\1K2=GV_P"!_D<[KUJ'\171Z[17FEGXYU.R(2X6.[C!P2WROCZCC\Q72V/C
MO1;L[997M7])EX_[Z&1^=<U7`5Z?V;KR.BGC*,^MO4Z:BHK>Y@NHA);S1S(?
MXHV##\Q4N:XWIN=.X44#D44`%%&1ZTUW2-"[L%51DL3@`4`.J*YNH+*VDN;J
M:."")2TDLC!54>I)Z"N+UWXIZ%IDWV/3?,UG46.V.WLAN!;L"XR/^^=Q]JKV
M'A76?%=U%J?C>11;HWF6^BPG$2'L9>?G;VR?R)6NI8648\];W5^+]%^NQG[1
M-VCJRY%J>J>-F(TEY]-T`'#:@04N+OVA!^XO^V>>>`,9KJ].TZTTJQBLK&W2
M"WB&%1?U)/4D]23R3R:LJJHH50%4#``Z`4M93J<WNQ5EV_S[O^D5&-M7N%%%
M%9%!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%13V\-S&8YXDD0
M]5=<BI:*`W.1U+P):3J[6-Q);L1Q&Q+IG^8_.N0U'P?KEIG%JUP@_B@8-G\.
MOZ5Z[17?1S*O2TO=>9QU<#1J:VMZ'S[)]JL9R4>>VG0XX8QN#CV(-78?&OB:
MT!$>J2.H`&)563]2,_K7M\]I;W2[;B"*5?21`P_6L>;P9X=N&R^DVX/_`$S!
M3_T$BNY9K0GI6IW^Y_F<O]GU8?PY_FCS)/BOXCB`#0Z?*,<EHF!_1A3)?C!X
MC`(CLM-S[QR'/_C]>C-\//"K'G2\_P#;>7_XJK%OX(\,VQ!31;1L?\]4\S_T
M+-2\9EVZI/\`#_,I8?&?\_/Z^X\=;XF^/-7E\G30AD;HMC9[S^NXU?LOASXU
M\62++XGU6>WMMV3'/,97_P"`Q@[5_''TKV^"W@M8A%;PQPQCHD:A0/P%/P/2
MLI9HH?[O34/.UV=,<,W_`!)-G.^&/!&A^$XO^)=:YN",/=38:5O;/8>P`%='
B117F5*DZDN:;NSJC%15D%%%%0,****`"BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g248385frr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g248385frr.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`/0$'`P$1``(1`0,1`?_$`+\``0``!@,!````````
M```````!!@<("0H"`P4$`0$``@(#`0```````````````0<&"`(#!000```&
M`0,#`@0$`P8""P````$"`P0%!@<`$0@A$@DQ$T%1%!4B,B,681<*<8&10A@9
MH;'!T>'Q4G*"8R0G&A$``0(#!04$!0@&!@L``````0`"$0,$(3$2!09!46$3
M!W&!(A21L3)""*'!T5(C0Q48X?&"PC06\&(S9"47<I*BLF-SH\,D-2;_V@`,
M`P$``A$#$0`_`-L+R/\`(S*W'BD,YW%DNPC)5RW5.)G\,WE4BB0P$]TI5TU`
M$Q0W^&VVKBZ3:+R/5U;,E9W*,R0PBYY:;>Q5CU#U5FNG)<O\.FACI@L&#%V[
M1ZEJPY`\X7D@KDBY)'Y<IK9NG[G:D?%U2>%(GW%[#`=9OWF_,`>NMG)7P[=*
MI[`#13P[A/>%@64=0=43\4RHJ&OL^HT"]4B7_J`/*`Q,0I<M8W>`<!_/A^IF
M$"F#N+WE(1+MZ#MTZZ^@?#9TH<+*2J';/=]"RN3K+.W#QO:;-C0%LR^#KFYR
M#YM8&RQ>N0<U`6&R5#+"-/@G5=JS*JH)0BE1AYHZ3M@Q653<."O7I]E1$![1
M`-NFM6NN>@]-:%U129=IV4^5(F4W,>'/+P?%AC%UNZQ9YI3,:G,J-TRH)):=
ML/F%ZS>#(MTQ$IP43ZCOW$Z=>N^^_IJI!(>19"`7MFIE-,#&/8OH2<HK#LF8
M#!MN!@$NP^G0.N^_7Y:X.8YGM+O:]K_97,RQ"#L;?UVWVZ;[["'SW`==1>P7
MD14QX%=@CM\_[M<E*`.X;["'\!Z#J`8J2(*.I4)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(L)/F/<BWQXQ]M-+W31;CVU#"7O[_
M`'3`('`2CVH>W_F_\736R7P_MQ5<Z).'&/5ZU1/65Q`INPK1XR8=,9%^=1=(
MJ8`L)3*ICL4Q>I4B]NPF#\']^MVZ>Q@L_IO5:9)$@`6>'T\%/^$>($YF2D\B
M\H6&^UG&56XTXJ;Y8R&PD8&6GK@YBWZJT=6X&-8-#M(6-LEBD42IMVKYZ@N!
M3`<Y``=M8EJ;74G3M;E^7RJ>;4SLPJ#*ED.#6B`)<^XES6@'%A"L3*Z$UC"^
M6;FQ/9&$([X[[(;5M)_TR'T0\7>0)V*KM9D/(@Y&RSY%)J\413QY5?:.Y;-U
M7+=%4?<'<I%5`#;UZZU)^*1[QK6A;.@#^&["2(\T71`*LO0@(H)T#'Q+9>3!
M,Y13-VG`1-L!@`VP]=_^.M=PX1+F&R*RUH:687#Q+Q7D$FN(BW<*LU]]RJMP
M[C%Z>G:)@`0^/SUWBI@8D1"^:9E[Y@C+>9;M_P`REM_(V>O&%15N2;:D[0,=
M/N343(&WZJ@?J")A#<1#8-?0RGRFL;]J[!.V1$;=FY>9/J\WR^QLOGRMIC`@
M;2O6BKU`2YR-TG94'9C"4&KPH(',8H=2IB8=CB`B'IN.VHJLHS&C&)XBW>%]
M=)GF6USL,MT#Q4Y$$O;^$0^(]!W^.O.:7N$7B#EZHP^[<N>^I4IN'ST1-$4-
MP^8?]_0/\1T11W#YZ(FB)OHB:(FB*&X?,-$4=P^>B)HB:(H;A\P]=O[]]MO[
M=]$4=$31$T1-$31$W#1%#</F'^/R]?\`#1%'?1$T1-$6%OR[1B,K1FJ3V1;P
M<<U8E6>3CTJBC9FDJJ*8()-FQ3/9-^].':DU2V[MA,82E`1UL;T%G\JKFB6U
MSYI=<.Z$2;`(1)<>Q4%U?:Y]5)EN;&5@CWB,/U+3IGJ%7"L[-DB$LC6=6B9@
M:EC."L]?7KJ=WR:NV+('"(!>1D6+YO2(@?N!T7/L)K/3LV^XJ*]FMQYE9,$U
ME`]A8UTOF3'-<'8)<<,#<07GPQ$8-Q.N"JS3]56<QM+.E>%QBYT(``6PNV6=
M]BK'"-G.%_#9F2Q.'3A.R<VN8%3QPDZ?"J67E:!A6*=VVVK.57(@Y726N2:J
M2P_!;H;KJO*QK<YZW4$J2`962Y4][H6@&H.%@W6-,>Q7/2PDZ=GES2#.>T`[
M/!!Q`'>/1Q5^OC#Y>SGC^\+?-_EO5Z)$Y'F,1Y[@)-K2YJ8<P,;8AG([%%3<
M-UI9DV>N&:K=&=,LF)4Q`52%`?P[ZU[^*-O_`-[0G^YCUN^A9SH)Y=03X[#^
ME7&9`\ZWD=QE+<LJG8.`?'DEEXB83QUR\R2DTY'V5Q%MN,60(A"59L(U8M(!
MS/Y@3(Z`3)D*VC42HJ@('$""?6^6#AXQ68#BJ_\`-7SQ2V$;9QSQG@''.%U[
MSFSB%7^:4_+\G\H3N-J-6L?VYFDI4L:0CZGURRR-BRK:I`BZ34GMH,B@GW',
M`;@'.*0"ZLB><S-]BQUXS+#Q+X9-\NY+\DM3S*-<Q1D/(88V>X\R%B-B@5[&
M2TZ\BRQ[BL,Y8KQ5TZ7]@ZL>D0Z.QU.W2_@D!MN7;8>3*%`\BGD'>YE/D*N0
MW&GQF81Y+7RJQ.2G5BQC#S:+22E[=%TC&X1B#.)LSAQ&J-33!7RAWI.PRA`*
M(#KVJ#/:C+FADX\YHL@>V''>O'S+)*>LEEL@"2XQM"]CACY&/(7<_P!A7OD#
MP9;T+C;FW"B^=\+Y5IF3$;RVC*\I&&GJ[3<P+RC:-_:EXM<`LD=I[9C-$E#E
M]P0*)C%]ZCI*+5#9I:&T]0P`@1%O=9VQ@O#+<PTW(8)4PSXN\1.X\;;KE3G@
MEY_KERGYOXLXIY/P9A:CQ&=6>5G%%EL99T/E&YXZD,81[B9;PN8D&]=9T4S^
MU1B!O8^QRKWZ=8Y2J%UBN8Z?K:*<T.\4S"3$6^$7[3O!*RV1/D3I`F/(!,#N
MM*EW'GGVY,6!KB#-%QX-4JO<0<@\ZWW`F;RA$YU^YY'2R<XOLM3*]::UCI6M
MM@=U!N1F0'IG+LJHN2JE1#VRD.;SYV+^SF6.!]5Z[@UOW=RVHU2]Q!#?;?Y@
M`@([#L`E'H;K\-<E*U"N2?//E%P+MWG'X^6C+%XO&1'-8P_FSQQNK'-*S=@A
M6?*Z<##,/2Z"+M'W!0QME60*JU:D`Y41:=-]]0I5<^5WE6Y%^*+'6'<*V^BT
M/D%9L0<4J9E'/>9>2')J'H&1\RW,@?37BK8=I,7!6NW7R\HR":ZH.'S2/BBI
MF(F"_P"`1$D%7S-_F(SLAF3!N#>(_#%AG2]Y[X"QW.FO*W?-#/%\/3JTL[.,
MM7;:N>NS";A2.8BFDD9FH95T_733["$[E"HIA4NCYT+#DKC!X[\B<8>*;W*7
M)SR-V"]5?%^![7DAA2ZK2W6'E)5'+4U:\DGAWQ0KD$M#*?2*D9E4<)'`QP3[
M1*8D%+C?SVVV.XO<I<]7[AM(T*]\5.<6,>$MWQ"\RO'2R[FS7:8I\!-64EGB
MJXI'@S@I2R&%LBFDL5XBD0X*D!00+,4PJ^.Q^3-6N<HO(!QP2P5-VEUP=XV8
MNY!HR4!;8MO*Y9<9)A9"7;4YG'SR49#UE:.68`F+UV^,B!1$Y@(4@@**B"L8
MXL^?.5S2ZY>57(7'G'%>R'QIX=V7F9%H8:Y&5W.-(LM0A&KM1;&MFNL#7&4;
M5<DLG2*2+U)O]R:(&,;M4-V;#"F&Q=4/YULW/^'V*>33_P`?=IK5PY<YBQ!A
M7@CAZ7RY5SO<_P`ODZJ'FY&[6&P-HTY:%18)^R7(@HX:@[>-_;5]HA3B)2B"
MJAXD.5G+KD/SC\KU,Y1QMFQM_)2Z<;H*F<>IFU5Z\5["Z]@QK*/;8UI=MKT7
M'-['7+=(,DY-L\'\2B*Q`,4ABF`)"DW6++ES*SFIQDXG\B^1",:$TYPGAK(F
M36<*<#^Q+R%0JTG,1L:Z%/\`4*S>2#9(BPEV$$Q,.B@+7YXE8-\M&2<$\2O(
MC&^3]]9LDYQ5QWE[+W&#,<36(;B%_)O(I_N3O&]#0@(!>Q5NV0E>D$TV+\JQ
MCKOBF[C`!0,8IBKH^3WF,S)CS./*S'O%GA',<H<:>/ZO0EBYIY-6RW6\:*5$
M)BJ.;PYK&+*Y+1L@[R#9X.HME'KP@G03#VSIE'N[1,0#>NO,?FDL09AX98@X
M=\3+3RSF><7%^.Y/8R?,[_!T!*JTUS9(^.F5KPTFFCA!FQK-;7<N7:R+D53/
M42MB)G]SO*BH`4A<@?.!G/%V3>>E=Q;X_+!FG%GC>ME;1Y)97;YQK-830H,Q
M3(VY2$U3JC,01Y2P6R):.7"QHY(QDR,FHJF7`3%($)`%5NS9Y>[J^REA_`W`
M7BC+\Q<OY)XJU;FU88R9R97<.5>BX"N)&HU51]8)AC,F?WRSK.@1:QI$@3*J
M)0.I^+8LH`J0WWSX1IN/?`C-O'OB9D/.EHYY9&R?ABN8.;W"OU"]T7,>+V#Y
MG-TJ6?R#5>OR8(W%B=FN\]]LBDQ(9UU']/0I#>OMY_\`FKRUP,-46MIXCTYQ
M(,..5;S_`)C+D7E'CS&*D;*R"1`L^&<)13UA.6/-&0*H]25344;-&S$W8405
MV-TA(+P,@^2OEK9O)GXG,9X*H$+_`*4>;?&BRYOM5<M%DK<=:)F,D:S$6:1F
M'RZD!(2L)+89B95!<C-JY%*Q*+'3[DNS?4A-BEO$_EI8<?N/7DES_E$^>,[N
M\0^2V\\5\/8TLU@ISR;G[M.R=>KN/L7XV>Q\+7V-8HBDG(BHD,B+URT0*JH=
M140*74*5<%0?+[D6)><Q,3\L.'TOQRY2\3N*TKS(:XJ8Y;K.2*=E?##-G)J$
M>5?(T%'I-8Z;CYQF2.DD56JGL+'$Q!.4HAHH(5LE;_J%;U'Q5,NV:N`URQ)C
MK/'"'D)S-XPR_P#.FH6^?RC'\;<.2F7[C4;'"1,21S1"6.+C.R(=+BHJ9)9%
M59`O<)"2D`KW_+A5YS(&/8JIU9BXF+"H\9BA"H./9.]+(@>-1<D3(8BBY6#A
MR7WNOZ**HJ?Y1'6Q'0FHI\MK:BMK7!M*X0Q$>SA@X@GC"S>;-JHOJRVJK9\B
MGHQ]O)&/MB"/3;\ZTPN5)V\A;X7$6.UTYBNX<A9"JU]XC(QK0EKNJS]2R9/O
M:<B]=,V9/O-M;@DP4,ON:.CFW;U';6YF0,F-IWYK61$^J(>1`DLEPPRI>TF#
M",0A`.<Y5EDO)H*5TM[RZ5,F%QB2XXB3BMV-B3"%P@KA_)[8:>UX_>/O!.)K
M;6K=7L88BN&2<M2%:L\!8F4%FG-DXRF;37Y%&,E7;E&9CG2#@AR]IO;*?H.Q
MAU7W3*AS-^K-0Z@SF5.E5515,DR"]A8'TTAN&66@@"!`:8B$3:;U:<^KH1E5
M+1TUK6MB?$2<9B3$[KK_`)EDT\/_``PJG/7P^<N>*%XM=DH-8R[R`;-9&V51
M"*?V"-3K</BRU-CQ[:935C^]9W"D2,"H"($.(AUVUKU\3KL>OJ8'W*%D.]SH
MQ])6<Z$>105!VEP]068'*WAPQ=EBW\U+C*YCR/&O>;/#7'/#*ZLV475ED:A5
ML<Q*43'7FNJ*M2J.K)((I"99%SNT*<QNTNP%#6N`%\+H^JQ9KL[EY69/#C&7
M"7XYY!P/RRS3Q>S5Q]XLQO#E3*=*J^-[BZR3@J.91J3>%M=7NL(]@&EB:R,;
M]6TD6H$5:*G_``AL`:F"8MRJC&^*G&\7D'QRY$)F3+T[*^.6/R>QISJXOH^V
M3>8'F6:V$+99C)-FDFP21I/ZI95VB9G[:93'!(``A2@""B*FZT^,W$5]Y0\O
M.1UVM%JL#?F5Q4KG$G(^,EFT4RK<=1(%*3:K3$),)(&F2SLBWE%"B"W>DF?M
M,4!`-@XE@<8[?U?0N1>385:]QL\)T-A6;CE,K<Q^0O)*I8\XTW;B-@.@W)"J
M5"!Q!A>_1BT%+(F_:#%`U]NK*OK`Q93$F0RC9!,O:3<H"7N:]S0Z#GMQ0C!Q
M%UURZWLEO;@<`6E6GXM_I\)CC;=^+N3:GRUR)EQIQ!B<@U#%6,)[&V-*9&MJ
M'>FK]!RR5F:L1M(RMH1%U[BLJ\.LY=BF0O8F`;:S?3FHJ27F+#G;OL&2#*88
M7$X0,6^P7K%=24&8_AA;D38U+IP<[$8^&TG#LC&'<K>V'CMC<:8"Q7Q*FLBW
MQQ1<0\\H?G>DZ?UN$:6]S<V%OD[>I3``YA:H5U5P]."CCM55,`;@`;ZSI_3O
M3V;TQK*2H<:A^(@@^&)MA`;(F"P"3U`U!EU7R*VF:V2UH!!%M@`C'>0.S@MH
M3&O)+&63_;;14ZTCILY2"->F#E8R@'.'=VMRK&!)][8>HI&'?Y!Z:K+.]&ZA
MR)IFU-.Y]*/?9XAZHCO@L_R'6F1YZT-9,Y-2?<??]![E8?S+\2^$N:?,WAKS
M/O-NL<#:N(4L201I\/'L'$#EAI#V5I>*9#W!PNLB[9M*?<6XOVXID6W.H8O:
M&^^L4ESF.9CPN(C#=:.';Z5EL'W-$=Q%RHQS-\+*/*[D/R$SI7>5-WPBTY:\
M=H+C9GZJP^*\>WV3F*A5F[IM!N,?W&XINY+&@/`>"66(Q2,9^D`@"B0F[PY1
MQ>X1QC\RF+19[RK3C+Q4U;'O(/`/(-;,MGF9[!/CZ#Q^L:\-7AXV,LM6(]:.
M@R/(*DD72K.PA]&0OT27>W#<1[QWVT416*_E5XL[7P_X@>.K&''*%Y>9OR!P
MDS7DJS4WDKQ>CL1&SOB>.RL_FIFP2#C!>1'1:GE6KV#[R,<[8(/FZC8B!%C"
M)#G(8IC'L4I\&_#;F#/GC[YYX@Y5RV;\$6CF!S=5Y48JMN3"4N7Y#5MU37%/
MEZ1D/+-<K;G]FHVF>M,`JY>0J"Z::+<_842B!1&4C!7M-_!G-V^.Y[ON0_-W
M)^<,F>0CCMCS`V4<A_RSIE#4J)\:G.>`L%2@ZTZ&-&*`A$431JX#W)%5*9<X
MJB(%"X8<\'MHI5DS#<\D\P%<BV#,7`2R\`G;*K<>*%B6HTNC/DR-J_9ZG7*C
M,^TM(PJ:BBSQ-X9<\DY6,<RZ90*0(A%(JMF3O#]#73@/PTX>UC/MJH.3^!LO
MA^Z<>^2D948B3E(?(N'HUS&Q%@GJ`^?C"R<-,LG2B;R/,Z`NQB]J@;;"AZ4C
MZ%5;Q]^.:W<,\O\`+?/>2N3EEY.97YCSV-+3D>QV#'=;QRA&S^.J[)5U,D!#
M5F0=QK6$=,'R:;5H!2?2(-B%$QS"8VI0E9&<G8^JN6L=WC%EZBTYNE9)J=BH
MEMB%A,1.2K5LAWL'.,A5(`F1,YC'RI"G#J0P@(=0T1:^&//`3>8%E@S`V4O(
M9F/+G`'C+DZ%RCA[B:\QW3ZS)%>U"6=3M'J5]S%"/!LEJI=4>NQ]MH+5(%DP
M[1[0'8"157.4?AEOV6<V<I,D\<^<%]XJ4;GM6:[4^9^,(?%]1R.WR*U@JVYI
MJL_0[%8W[:1QO9)>H.56#E=)-=,2',8"[FVT0*Y+'WBXQMA_EKQ$Y&XYN\K`
M57AWPOG.&5%Q(I"H2"<Y4I&19/65JEK@:0;.$I5BFR`%D2LSD75,8X&)OVZX
M.F"/+8TF:+>$"HNM]U8<7'BTYE\GN8?FDK`YXR7P^XS\L\PXCA;.V_E!5[C&
M<D,2EQ@UB[+)XQM4W)-92HSK-9NM%.GS?W45$')B'1W*&CW\MF.8TBV$!:2=
M@[U'VC_8`#87F[]95[61O''6\BYYJF1?'=S4EN*F?.-_&2L<&\FR\#CBNYJJ
M4WA>!;H*5:HSK6<<1<''91J'T@+)K-')W#8YB&703$":^VKHZW+J.75U\ATJ
M5/$99<?%#>67P.PV`[(KJIJJGJ9QIY;XS6FVRQ5)H7A3Q;BFN^,&I8^RY:FL
M+XW\QY$S5]388!G,SF=+GE*/DOWE(V=^@_8)5EU(V"8</""W3=$3()4NTP`!
M]?*N^(4H\X_"K-\M.2G(+/5/Y4FPXQY2\9HGC1F.N2N"*7EN?856N-Y5!@\Q
M1;[3+LU\;FFR2HDE?I4#JN"@(IJ)*"!B"D1"U5/_`-IRR1F5?%OF:G\EW-:N
MGC@Q&?!#\G\KH>9A<YXPEZU6ZM:HUPR>V`IZ!+SD-7>Q-X@=Z9L983$#N*&B
M14AR_@XQO9N.?-;`-FS?;_J.5?-2:YQTK(E<K4;$6'`>5AF8.>I@U]NL^?L;
M42KR4)LH=S[`.T'"B9B)]#Z)%=^/_#K?Y%;F-D_E-S&G>1O*+EMQ7D^'O\XB
M8EK6-JWBS#;MC))-VE9QM`3#ED_F7,P](_>KJNTOJ5DA`.P#F$4$BI5RWX,8
MS)V/N&./#<BY.':\1.#')+A.VD28Z9/E+PRY&X%6P4YR&LT-8D4X)_6$%/N(
M,2'73<F#VC+)A^+1(JKGEHNSO'=1&QUKZIK<%H):+8SS=7V'-=92!%&DDZAE
MB#W)3#UFJ*(+F`?82$W9L8_<&Q/0[+CF=2^GJ<+LNQQ+3[SQ`M#A"U@OOM($
M1!43U4JV4D]IEN+:@M$2(QA`W0V[.Q:/699]S,2JKR48P";LG>@NM&0S**5D
M.TPJ$=OV[(I&SA^/=L*W:4ZGYC;F'6\-%)$E@EL+\.R+B8<`3<.&Q5MD`ESL
M4Z6#!UX-D+=BM9E@*FK]4B0A%#&W*06B11,)B]HCN0P"/X3#U$=>M+,1@C\J
MS66UP$2"0MYC^F:2!#@UD=<Q3=[GD5:3GVV'8$J31R%#U]0#?6@WQ,S`>HDJ
M4`?_`%\LQV>T[Z?6K3T,'#+JAQ!]L>H+8V0.51,IB[["'3?IZ:UV:08EI!!<
M?6LU:8M'8NW7)<DT1-$7`0/OT$-NG3_G\-=3Q,)\)L4V(8G<&P[#MU#?KL/P
M'4-82?M8%J1('A)!5)LGX9IV58\S6PQR)'X(B1K.M`^GEV9P#=(4G28%,=(A
MO\AQ$H_+609-J;.M/U0F9>6FFC:QQ,#W0([XKP,ZT[E^>4QE546SH6.;>#V[
MEB6SGQ,R'C)LM/Q'U-PK[14BWW:%0,66CDRF_36?L$EO?340#K[Z.Y?B.P[:
MV#TKU$R?/7BEK"*:M</[-Y&$\`;8QW%4AJ+1.:9,TS*-G-I1]XR\<2#"$."D
MK&G-W+^+!;1\QVY%J:"X)&CIM94MB9HIK[+)L9KVS+JJ$3`-B+`H3IMTUZ&H
M>F&0Z@8ZII&^5KW"]EDLF&UMPCM(@5\^G.HF:Z?GC+JV<Z?1-,8OM<`ZV$>&
MQ9+\.<VL"Y54:L$[(:F6=PB)OVY<O9B%U55%?;*BP?J&+&R*AS%_"5,X'V]2
M@.J/S_IMJG3P+GR73Z(>_*B\7;1[0]$.*N/)]<Z?SN;AE3L%3#V7^&-NPW7J
M\`KU`Q"G`1[#%`Q3;`)3%,`"`E$!$#!L/J&X:P!I<8XFN:08$.L*S*+<(>""
MPW$6KZ0.4WH._3?X^FN0M&+8HB"8"]`.!M^WKMZ[?]NVH!B8+D6EMZ=WXNW8
M=]M]^FW_`#WTQ-CACXE.'PXERU*XIHB:(FB)HBZCJE)Z@8?3\H;^OI\?XZ@D
M!N+8N)<`8&]4YRAE/'6'Z79,B94N,!0Z'6(Y21L%HL\BWC(:,:MRF,<[ARN8
M"G4/T*1),#JJG$"D*8P@&OHH*&LS>LEY?DTI\_,Y[L+6M!)LVG8`(VDV"*XS
MZF5E[/,U;FLDC?>3N`WK%7`9'Y%>39P8<2#=>+?!8ZZJ+K+SQHM7.0W).***
MJ#ICBQDX!-WB;&TJF`%-/+%&4>-S[M2I"/>6TYV5Z?Z8RQ+S0RLTUTX1Y,<=
M-2Q'M33]Y.:;F`%@OC&$<7-1F&I29<DS*?*FNCBN>X@V-%L(';\ZRG8HQ!0<
M)T2OXWQ?5(BFTZL,S,XB%BD13*D)A`R[UX\.99Y*2TBOW+.WCE11TY6.8ZIS
M&$1U5N89EFV;9@_,,SG&HGS#$N=>T"YK6W0`L%UD+%DU/34U/)$IC<)&T7G>
M2;XE51U\Z[DT1-$31$T1-$6.+GCPUM?*^#"'KEP@:J9-F5N"LY'RCY$PEV,4
M0".W-MW^NK5Z;]2:'0\YWG:.IGM+HXI99"W_`$G`_(JYUGH;,=43.913I3(`
M`!T1<(&T!:\=Z_IQN4DZZ<K0F=\&=BJIE"FD8J_H*"!R]2F!&+>E(&^VW38/
MGK8>3\3VC93&NF9?F1<;(#DV?[86)Y?TRU+2MY+IE,&@7AQ,3WP5%I'^F5YN
MNB`9OG'CJX_$`=@JY#;AVD$`#=0U3$H`(!UV'?7TS/BET5+;$9=F8[I)_P"Z
MO=EZ*SB19,+''<'#TK8X\0G!O*O`7C79<,Y;L%+L5IF\JV&]-WU#<3+R#3C)
M6'@(QFW%:<C(MX#PA(8XJ![?8`&+L/4=:R]6]>99U#U5^-9,R;+D,II;!S&X
M22+;HNW_`*HK,]-Y36Y93SI=21A<Z($8_,-JRR(;@F`"42["8``=O0!V#T]-
MPU6EFS>LC(`@!=`>I=VBA-$31$T1-$4!]!Z;]!Z?/^&B+X11!9,`.02@H42&
M3$`,':(=2B`B(%#8.G3TUTB3+9,YLN+IWUE`Q39>%\`R%H5F^;^$V*<O_723
M1B-&MSCW#DGX!,I&[QP</SRL24Z;5T!Q*`F,3VE?D;5AZ6ZDZGTZ]LJ?--7E
MWU'7M&X$W#=>L&SW0&19R'36R&RJDCVFP$3Q`6&;/'##,>(DG;V6@WMJJ[4B
MIF]LJJ3N10(HDH"A5Y)FBDH\B#"3X*%,7;<>\=;*Z7ZCZ=U"6T[)K9-<1$RY
MD&\(!Q\+K]\3N5&:BT-G.1.-3)EOF48="++0-L2!:(0W0&]4HQER[Y"8!0*%
M3O;N5@&J[?WJG;"DG*^)#'$RQ$"O5ON+1<4@V!1NH42[>FO6SSIWI'5#2[,*
M1HG.!A,E>%T=YPC";=X7G99KK4F43O*T-40UL(MF^)O8,1L[ED5Q)YCZ*_-]
MOSG1)*CKE`@!9*DH>S02P'`.U56.5,UF6(#ZB4@.=@#UU3FH?A^S*4.;IJL%
M0T?=S1RWGL(BSTD*T<EZPM?"7J&E$I_UY)QL';&!]$5D@Q3RLP#F8B(XZRM3
M)]PN`&&,":;L9Q(QMA]M6'EC,I$IPW_*"8[?,=4]G.A=5Y#,=+S.CGRBT6X6
ME[(&XXV@BU61EFKLAS9C7T53+=+<3[3@T@B\0<0?0KC0,GT.!RB`AT-W!VF`
M?B!M]A#^S6*L;+:^'WHC^E9*"7@%ABWA:HF5*4Q"B/Y]]A^'0-^HZ[06FXA+
MKUSW#YAU].H==`YIN(2!3N+\P_Q#4P*@D"PWJ'>7?;N+O\MPWZ?PWTNO0$&Y
M>3.3\+6XQW-6"7BX*'8('</9:9?M8N+9HDVW5>2+U5%JU3W'U.8`UV2)4RJ>
M)=*UTV:;FL!<3V!L25QF3)<H8IKFM;O)`^4K"QR-\VV`:!/EQ1QB@9[F%GR7
M7^S5BH8J:N)"I'L"A_8!O)7)F@[.\3;*'_5"-;/"E`H]ZJ0?C"X-+=#-4YJ#
MG.K'2,FTO*`<Z;./VQ9>8,,`W]IP/`K#LTUQEDEID92U\^I)@"`2V)V61)[A
M#BO%P]P!Y#<M[O5N1_E0M+2T+5]\C/XRX8U$X(8)QBZ#M78R=VCTW+U*_7%C
ML4#%<JN&Z:A?QJ'$.POT9_U#T]I2EFZ8Z3R'2VD8)V9S0#/G7XN3[TMHV&#0
M0;`#:NO+LGS;-RVMU(0(^S*!N&R,+!'=?O6<2-9-6"3=HR;ILVC9`K=LU;I%
M1;H-TB$(B@B@0A$FZ")"`!"$`"E`-@``#5'8'\XS7Q>]UKGN)<\GB3$GTK.<
M&"6UC0&2VV!H@!\B]77:H31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T
M1-$31%\[E(%DA3,4IR''M.4PCV&(8!`Q3E#<#E,4=A*/00'KK@\$@82X.!B"
M+P4PL>"U]K2+MZLIS=P+P%F9-9^YKIJ393>\*5EI`-(ER=57J"[^+,3[/)=@
M[_A52WZ^NK)TOU3UCIH"1SQ5T?U)L3`;FNO;W%5_J'III;4+C-?*%+4_68!:
M>(N*P\YR\3>=JVHI)XVDH3+$>D@J(M0^DK]G2*!B@/:QD5E(UZH=,H!W).`$
M1]"AJ^-.]=M*5SA(SALRBG1M)BZ7_K``BW>U55G/2O4]$PG*P)\K9A(:>]IL
M]$5B8R[AO,F+951*]4&_4@6BABMY"6K#MFBD4@AW`C-(('9]HCU*=%QW!JZ\
MFU-I[.Y/^$UE-/EN%K6S&DG]F,>XB"K6NT_F66$G.*8^9!C$L(:!LV88[S>H
M4?F3RXPP<$L?9WR,S8HE]P(:3F#6>NH-P$H$33B[#]R22*0/S`EV``=`]=?-
MF?3K1&?B.8Y93&9'VVM$MY.V+F820=QO7UTFL]090P-I\PF2I=P8TN+1W`$6
M*Z"K^;[F[4DVP6`N+;\W+^FH>P4LT(\.`[]ASNZ_),4S``%Z?I;]>N^L'S#X
M=NGU<\NHQ44COZDPO_WHK*Z#JOJJE:/,3&U+?ZTM@/>?"55I'^H>SJR`X27&
MS%+TQ"_B6:7"XL4U0`-@.D@I&/\`8/[!^.O`_+!IFSE9G5M/_*E?2%E$GK%G
M3K/*2#^T0?6I5G?ZC7D`=NJ2'XSXCC5A$2INI*Z71^F38.G<@E'QP%'_`-?7
M^&COA;TS/&&HS;,#+VAC&2R?VFOBON'5?-YP_AJ5K]\7.]8A\JMKG?-1Y1L^
M/C5/!<'6HV5D5OIDF.&,0/[W9DE%`$I2HOY56T%9N3`.X*'2)V[;B(!K(:+H
M+T@TK*%1G4R>]C!:ZKK"UI[1%D1PCV+Y/YYU)F;W2:6:S&;<,J6,0A?`@$]L
M56C%7B5\E_.638VWG?GF[X]H3HI'AJW?+<XO60'""J@*BVC<>1SQ.@U#O*;<
M#.Q%1(0`!;"(=,=SGK#TLZ>-=2].\LIJG-1'Q2)0E2X;^>0)C^RXV^)>O2Z7
MU'J![9N;3BRG_P"*2YW<VT#M,.Q;'W$/QZ\9^%%?)&X7I+8ED6:_3SV1[&)I
MO(-B]PJ0./K;&LF5:.9+BGO]$Q*V:$WZ$Z:UGUKU&U=KFM$_/*IPH`8MIY8P
MRF[C`7D;7$DJRLGTYE>3M)IFDSC[Q,3^@=@5\;<IBD$#=H#WB(`4=P`!`.F_
M:7T'^'IK#@YKO8(+1N7N#$!X[UWZE2FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB
M)HB:(FB)HB:(FB)HBXF[=OQ;[;_#?_H^&NN;APC%BA'9'YMBY-C&R]=2OL=@
M>[V]F_3?\N_]W37:,4/#%=;\,?M(1XKH'Z/O#U[M_P#W>W?8-M_\F^WIKHF<
MJ/VMW&[Y;%VNYF+WL7"/S+R+%^TOM+S]V_8/L7MG^O\`W)]!]H]K;]3ZG[I_
M\+L[?7N^&OIRSF>8'X-'S>*SD^WBX8+8KX\Q\EY8_BO)\K"WF8<,..*Q8E^0
M'^SAL^_F?_I\^Y?5I_7?LX%!F!6_'L'_`-?B"H%W]=OP_/5X9!^8"+?P/\3N
M^_A@P[?XCPQ^7<JCSC_)^/\`Y?E^9B^XQXH\>5L^2Y8N;K_L6;G^B'.(?JG]
MK]IEOXH]O>';['[E,5(4=]NS?X>FK6H/S)8?MO)<S;C\K^XL+JQTDB8&LP=C
MOWG*D;0/!A]8C]R/RN%#W"]WW-.1!E[GP^H^VJF=[;;_`)/^K7ISOS'X3RAE
MF*'NF1^\%U`=)_==F'<T?,Y7N8/_`/SY?6-_H/Y>C.^\G[0YD#)X![FWZ?OA
M;1&M?^;O';YZPC4'YEN0?.<[D_W7R\?^E"9Z%DV2_P"4?-9A,PS[8<X3P.^!
M,OY>U9X,+_Z<?VTU_P!/G\H/VK],7V/Y3?M/[5]/L7;WOVK^CZ;;^[^+?UZZ
MUTU)_,?FC_-?GO-6_P`3S8]W,V]ENY6WE'\MX/\`!/)PV\KEXN_#XO2JQI?0
M>R7L[/:Z;=_=OOU[-_=_4[MOR[]=O37@MAR?!CY?#%'Z8+VS@C;A^1?<7MV'
MM]/X:-Y>#P^SP7,QVH7MZ]OS'?;Y_'7)F"!P0A'9O[MJ&.U<M<E":(FB)HB:
)(FB)HB:(O__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
